1,5-Anhydro-d-fructose attenuates lipopolysaccharide-induced cytokine release via suppression of NF-κB p65 phosphorylation

Biochemical and Biophysical Research Communications

Volumn 380, Issue 2, 2009, Pages 343-348

  Meng, Xiaojie ^a   Kawahara, Ko ichi ^a   Nawa, Yuko ^a   Miura, Naoki ^b   Shrestha, Binita ^a   Tancharoen, Salunya ^c   Sameshima, Hisayo ^a   Hashiguchi, Teruto ^a   Maruyama, Ikuro ^a  

^a Department of Advanced Therapeutics ^*  (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

1,5 Anhydro d fructose (1,5 AF); NF B p65; Proinflammatory cytokine

Indexed keywords

1,5 ANHYDRO DEXTRO FRUCTOSE; CHEMOATTRACTANT; FRUCTOSE; GLYCOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE CHEMOTACTIC FACTOR; STARCH; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENUATION; C57BL 6 MOUSE; CELL LINE; CELL VIABILITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME INHIBITION; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; INSULIN RELEASE; MACROPHAGE; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSLATION INITIATION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CELL NUCLEUS; CYTOKINES; FRUCTOSE; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PHOSPHORYLATION; TRANSCRIPTION FACTOR RELA;

MURINAE; MUS;

EID: 60349098894     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.01.084     Document Type: Article

References (32)

1. Novogrodsky A., Vanichkin A., Patya M., Gazit A., Osherov N., and Levitzki A. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264 (1994) 1319-1322
2. Lin W.W., and Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117 (2007) 1175-1183
3. Yu S., Bojsen K., Svensson B., and Marcussen J. Alpha-1,4-glucan lyases producing 1,5-anhydro-d-fructose from starch and glycogen have sequence similarity to alpha-glucosidases. Biochim. Biophys. Acta 1433 (1999) 1-15
4. Baute M.-A., Deffieux G., and Baute R. Bioconversion of carbohydrates to unusual pyrone compounds in fungi: occurrence of microthecin in morels. Phytochemistry 25 (1986) 1472-1473
5. Deffieux G., Baute R., Baute M.-A., Atfani M., and Carpy A. 1,5-anhydrofructose, the precursor of the pyrone microthecin in morchella vulgaris. Phytochemistry 26 (1987) 1391-1393
6. Baute M.-A., Baute R., and Deffieux G. Fungal enzymic activity degrading 1,4-[alpha]-glucans to 1,5-anhydrofructose. Phytochemistry 27 (1988) 3401-3403
7. Yu S., Kenne L., and Pedersen M. Alpha-1,4-glucan lyase, a new class of starch/glycogen degrading enzyme. I. Efficient purification and characterization from red seaweeds. Biochim. Biophys. Acta 1156 (1993) 313-320
8. Broberg A., Kenne L., and Pedersen M. Analysis of 1,5-anhydro-d-fructose, microthecin, and 4-deoxy-glycero-hexo-2,3-diulose in algae using gas chromatography-mass spectrometry in selected ion monitoring mode. Anal. Biochem. 268 (1999) 35-42
9. Shiga Y., Kametani S., Kadokura T., and Akanuma H. 1,5-Anhydroglucitol promotes glycogenolysis in Escherichia coli. J. Biochem. (Tokyo) 125 (1999) 166-172
10. Kametani S., Shiga Y., and Akanuma H. Hepatic production of 1,5-anhydrofructose and 1,5-anhydroglucitol in rat by the third glycogenolytic pathway. Eur. J. Biochem. 242 (1996) 832-838
11. Yamaji K., Sarker K.P., Maruyama I., and Hizukuri S. Antioxidant effects of 1,5-anhydro-d-fructose, a new natural sugar, in vitro. Planta Med. 68 (2002) 16-19
12. Yu S., and Fiskesund R. The anhydrofructose pathway and its possible role in stress response and signaling. Biochim. Biophys. Acta 1760 (2006) 1314-1322
13. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
14. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev. 18 (2004) 2195-2224
15. Bohuslav J., Chen L.F., Kwon H., Mu Y., and Greene W.C. p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J. Biol. Chem. 279 (2004) 26115-26125
16. Sasaki C.Y., Barberi T.J., Ghosh P., and Longo D.L. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway. J. Biol. Chem. 280 (2005) 34538-34547
17. Chen L.F., Williams S.A., Mu Y., Nakano H., Duerr J.M., Buckbinder L., and Greene W.C. NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol. Cell. Biol. 25 (2005) 7966-7975
18. Ito T., Kawahara K., Nakamura T., Yamada S., Abeyama K., Hashiguchi T., and Maruyama I. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J. Thromb. Haemost. 5 (2007) 109-116
19. Kawahara K., Biswas K.K., Unoshima M., Ito T., Kikuchi K., Morimoto Y., Iwata M., Tancharoen S., Oyama Y., Takenouchi K., Nawa Y., Arimura N., Jie M.X., Shrestha B., Miura N., Shimizu T., Mera K., Arimura S., Taniguchi N., Iwasaka H., Takao S., Hashiguchi T., and Maruyama I. C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells. Cardiovasc. Pathol. 17 (2008) 129-138
20. Uto T., Fujii M., and Hou D.X. 6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide-activated murine macrophages. Biochem. Pharmacol. 70 (2005) 1211-1221
21. D'Acquisto F., Cicatiello L., Iuvone T., Ialenti A., Ianaro A., Esumi H., Weisz A., and Carnuccio R. Inhibition of inducible nitric oxide synthase gene expression by glucocorticoid-induced protein(s) in lipopolysaccharide-stimulated J774 cells. Eur. J. Pharmacol. 339 (1997) 87-95
22. Perkins N.D. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25 (2006) 6717-6730
23. Vermeulen L., De Wilde G., Notebaert S., Vanden Berghe W., and Haegeman G. Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem. Pharmacol. 64 (2002) 963-970
24. Viatour P., Merville M.P., Bours V., and Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30 (2005) 43-52
25. Senftleben U., and Karin M. The IKK/NF-kappaB pathway. Crit. Care Med. 30 (2002) S18-S26
26. Laskin D.L., and Pendino K.J. Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35 (1995) 655-677
27. Victor V.M., Rocha M., and De la Fuente M. N-Acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic. Res. 37 (2003) 919-929
28. Lauzurica P., Martinez-Martinez S., Marazuela M., Gomez del Arco P., Martinez C., Sanchez-Madrid F., and Redondo J.M. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-alpha. Eur. J. Immunol. 29 (1999) 1890-1900
29. Lukita-Atmadja W., Ito Y., Baker G.L., and McCuskey R.S. Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxin. Shock 17 (2002) 399-403
30. Wong B.C., Jiang X., Fan X.M., Lin M.C., Jiang S.H., Lam S.K., and Kung H.F. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer. Oncogene 22 (2003) 1189-1197
31. Ahren B., Holst J.J., and Yu S. 1,5-Anhydro-d-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice. Eur. J. Pharmacol. 397 (2000) 219-225
32. Mei J., Yu S., and Ahren B. A 90-day toxicological evaluation of 1,5-anhydro-d-fructose in Sprague-Dawley rats. Drug Chem. Toxicol. 28 (2005) 263-272